Get started

Eli Lilly (Australia)

Homepage: lilly.com
Alternate names: Eli Lilly Australia, Eli Lilly Australia Pty Ltd
ROR: 041jqqq20
OpenAlex ID: I4405272350
Health state utilities in non–small cell lung cancer: An international study
2016 · Beenish Nafees, Andrew J Lloyd, et al. · Asia-Pacific Journal of Clinical Oncology · 317
Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial
2019 · Charles S Fuchs, Kohei Shitara, et al. · The Lancet Oncology · 300
Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior
2017 · Shyam K. Bandari, Anurag Purushothaman, et al. · Matrix Biology · 231
PDF
History of illness prior to a diagnosis of bipolar disorder or schizoaffective disorder
2007 · M. Berk, S. Dodd, et al. · Journal of Affective Disorders · 231
Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer
2021 · Davide Melisi, Do-Youn Oh, et al. · Journal for ImmunoTherapy of Cancer · 223
PDF
Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention
2011 · Michael Berk, Alan Brnabic, et al. · Bipolar Disorders · 198
Multilevel Network Meta-Regression for Population-Adjusted Treatment Comparisons
2020 · David M. Phillippo, Sofia Dias, et al. · Journal of the Royal Statistical Society Series A (Statistics in Society) · 190
PDF
The “Efficacy-Effectiveness Gap”: Historical Background and Current Conceptualization
2015 · Clementine Nordon, Helene Karcher, et al. · Value in Health · 188
PDF
Impact of caring for persons with Alzheimer’s disease or dementia on caregivers’ health outcomes: findings from a community based survey in Japan
2016 · Amir Goren, William Montgomery, et al. · BMC Geriatrics · 172
PDF
Prevalence, burden, and clinical management of migraine in China, Japan, and South Korea: a comprehensive review of the literature
2019 · Takao Takeshima, Qi Wan, et al. · The Journal of Headache and Pain · 169
Ramucirumab Plus Pembrolizumab in Patients with Previously Treated Advanced or Metastatic Biliary Tract Cancer: Nonrandomized, Open-Label, Phase I Trial (JVDF)
2018 · Hendrik-Tobias Arkenau, Juan Martin-Liberal, et al. · The Oncologist · 168
PDF
Diabetes in Japan: a review of disease burden and approaches to treatment
2009 · Susan E. Neville, Kristina S. Boye, et al. · Diabetes/Metabolism Research and Reviews · 151
Purification and characterization of human RNPS1: a general activator of pre‐mRNA splicing
1999 · Akila Mayeda, Joseph Badolato, et al. · The EMBO Journal · 148
PDF
Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: results from a 1-year European outpatient observational study
2015 · Diego Novick, William Montgomery, et al. · BMC Psychiatry · 143
PDF
Systematic literature review of machine learning methods used in the analysis of real-world data for patient-provider decision making
2021 · Alan Brnabic, Lisa M. Hess · BMC Medical Informatics and Decision Making · 137
PDF
A phase II study of gemcitabine in platinum pre-treated patients with advanced epithelial ovarian cancer
1998 · M. Friedlander, M.J. Millward, et al. · Annals of Oncology · 135
Major depressive disorder in Latin America: The relationship between depression severity, painful somatic symptoms, and quality of life
2005 · Rodrigo A. Muñoz, Margaret E. McBride, et al. · Journal of Affective Disorders · 130
Recent trends in the use of antidepressant drugs in Australia, 1990–1998
2000 · Peter McManus, Andrea Mant, et al. · The Medical Journal of Australia · 129
Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): a multicentre, multicohort, open-label, phase 1b trial
2019 · Aung Naing, Deborah J Wong, et al. · The Lancet Oncology · 126
Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study
2006 · Martin Dossenbach, Yulia Dyachkova, et al. · European Psychiatry · 125
Patient psychological and information needs when the diagnosis is diabetes
1996 · Linda J. Beeney, Amr A. Bakry, et al. · Patient Education and Counseling · 108
Prevalence of sexual dysfunction in patients with schizophrenia: international variation and underestimation
2005 · Martin Dossenbach, Andrew Hodge, et al. · The International Journal of Neuropsychopharmacology · 107
PDF
Biostatistics Primer: What a Clinician Ought to Know: Hazard Ratios
2011 · Helen Barraclough, Lorinda Simms, et al. · Journal of Thoracic Oncology · 104
Relationship between Progression-free Survival and Overall Survival in Randomized Clinical Trials of Targeted and Biologic Agents in Oncology
2019 · Lisa M Hess, Alan Brnabic, et al. · Journal of Cancer · 99
PDF
Effect and Offset of Effect of Treatments for Hip Fracture on Health Outcomes
1999 · B. Jonsson, J. Kanis, et al. · Osteoporosis International · 98
Works count: 435
Citation count: 15,680
Year
Topic
Type